The revolution in high-throughput proteomics and AI
Science · 27.09.2024 · 385 (6716)
DOI: 10.1126/science.ads5749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 27.09.2024. Verfasst von Eric J Topol. Beteiligte Einrichtung: Scripps Research, La Jolla, CA, USA. etopol@scripps.edu. Hauptthemen laut MEDLINE: Artificial Intelligence, Blood Proteins, High-Throughput Screening Assays, Proteomics. Die Arbeit wurde bisher 35-mal zitiert (Crossref).
Abstract (Originalsprache)
The recent capability to measure thousands of plasma proteins from a tiny blood sample has provided a new dimension of expansive data that can advance our understanding of human health. For example, the company SomaLogic has developed the means to measure more than 10,000 proteins and Thermo Fisher’s Olink assays over 5400 proteins from as little as 2 μl. When these rich data are integrated with other layers of information from large patient cohorts, such as the UK Biobank’s genetic, health, and lifestyle information from half a million participants, we get new insights about the underpinnings of disease, the aging process, and the potential ability to forecast an individual’s health trajectory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Scripps Research, La Jolla, CA, USA. etopol@scripps.edu.
ORCID-Profile: Eric J Topol
Zitieren
APA
Topol, E. J. (2024). The revolution in high-throughput proteomics and AI. Science, 385(6716). https://doi.org/10.1126/science.ads5749
Vancouver
Topol EJ. The revolution in high-throughput proteomics and AI. Science. 2024;385(6716). doi:10.1126/science.ads5749
BibTeX
@article{Topol2024,
author = {Topol, Eric J},
title = {The revolution in high-throughput proteomics and AI},
journal = {Science},
year = {2024},
volume = {385},
number = {6716},
doi = {10.1126/science.ads5749}
}
EUVIMED